Generic Sweden Interim Report January–March 2024
May 15, 2024
First Quarter of 2024 (compared with the same period last year)
- Net sales increased by 22% to 42.17 MSEK (34.64 MSEK)
- EBITDA decreased by 6% to 7.14 MSEK (7.60 MSEK)
- Earnings per share amounted to SEK 0.45 (SEK 0.48)
- Cash flow from operating activities amounted to 10.11 MSEK (-1.09 MSEK)
Note
Generic Sweden AB (publ) is required to disclose this information in accordance with the EU Market Abuse Regulation.
The information was submitted for publication by Susanne Lundin at 4:00 p.m. on May 15, 2024.